Filing Flows

Filing Flows › Foghorn Therapeutics (FHTX) › Who owns the stock

Who owns Foghorn Therapeutics (FHTX) stock

97 funds reported Foghorn Therapeutics (FHTX) shares in their latest 13F filings, worth $168M in all. The largest holder is BVF ($28.5M). Last quarter 48 funds added to their stakes and 38 cut them.

Largest holders of FHTX (13F)Largest holders of FHTX (13F)BVF$28.5MFMR LLC$27.8MDeerfield Management Company, L.P…$21.4MBlackRock$12.8MRaymond James Financial$12.2MVanguard Group$10.4MEuclidean Capital LLC$7.7MVanguard Capital Management LLC$7.3MGeode Capital Management, LLC$4.4MSiren, L.L.C.$3.5M

Largest holders (13F)

FundSharesValueChangeQuarter
BVF5,842,000$28.5Munchanged2026-06-30
FMR LLC5,705,958$27.8Mdecrease2026-06-30
Deerfield Management Company, L.P. (series C)4,394,367$21.4Munchanged2026-06-30
BlackRock2,626,832$12.8Mincrease2026-06-30
Raymond James Financial2,489,978$12.2Mdecrease2026-06-30
Vanguard Group1,928,992$10.4Mincrease2025-12-31
Euclidean Capital LLC1,573,761$7.7Munchanged2026-06-30
Vanguard Capital Management LLC1,494,611$7.3Mdecrease2026-06-30
Geode Capital Management, LLC910,866$4.4Mincrease2026-06-30
Siren, L.L.C.720,720$3.5Munchanged2026-06-30
State Street697,469$3.4Mincrease2026-06-30
Ameriprise Financial558,685$2.7Mincrease2026-06-30
Renaissance Technologies LLC377,936$1.8Mdecrease2026-06-30
Candriam S.C.A.313,765$1.5Munchanged2026-06-30
Northern Trust309,775$1.5Mincrease2026-06-30

Foghorn Therapeutics' latest quarter

Foghorn Therapeutics, Q2 2026: revenue $16.1M (+113% year over year), operating margin -54.8%, net loss $7.2M, operating cash flow −$17.8M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most FHTX stock?

By the latest 13F filings: BVF ($28.5M); FMR LLC ($27.8M); Deerfield Management Company, L.P. (series C) ($21.4M); BlackRock ($12.8M); Raymond James Financial ($12.2M).

What is the short interest in FHTX?

2,455,127 shares were sold short at the 2026-10-15 settlement, 14.05% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.